Trial Profile
Influence of aflibercept (Eylea) on macular perfusion in patients with macular edema secondary to retinal vein occlusion
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 08 Nov 2018
Price :
$35
*
At a glance
- Drugs Aflibercept (Primary)
- Indications Retinal vein occlusion
- Focus Therapeutic Use
- 08 Nov 2018 New trial record